XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q1)Dec 28, 2024 | (FY)Sep 28, 2024 | (Q4)Sep 28, 2024 | (Q3)Jun 29, 2024 | (Q2)Mar 30, 2024 | (Q1)Dec 30, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jul 1, 2023 | (Q2)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1,870.78%53.64M | 163.24%436.5M | 145.03%220.13M | 598.94%131.6M | -17.13%87.8M | 93.79%-3.03M | 731.94%165.82M | 23,017.60%89.84M | 188.84%18.83M | 105.95M |
Net income from continuing operations | 27.56%37.27M | -19.61%111.82M | 2.38%41.22M | 59.12%25.14M | -60.24%16.24M | -30.75%29.22M | 0.62%139.09M | -20.21%40.26M | -57.86%15.8M | --40.84M |
Depreciation and amortization | 1.39%19.41M | 11.60%77.85M | 6.56%19.6M | 10.05%19.74M | 13.00%19.37M | 17.50%19.14M | 11.28%69.76M | 16.06%18.39M | 12.74%17.93M | --17.14M |
Deferred tax | ---- | 68.36%-7.1M | 32.51%-14.55M | ---- | ---- | ---- | -107.76%-22.44M | ---21.56M | ---- | ---- |
Other non cash items | -344.92%-1.09M | -886.01%-5.71M | -417.54%-7.94M | 90.10%941K | 2,114.29%846K | -11.75%443K | -159.57%-579K | 24.10%-1.53M | -75.97%495K | ---42K |
Change In working capital | 84.31%-8.94M | 643.65%224.6M | 252.98%171.25M | 458.20%66.53M | 3.85%43.83M | 49.76%-57.01M | 82.83%-41.31M | 182.29%48.51M | 77.48%-18.57M | --42.21M |
-Change in receivables | -50.97%9.89M | -14.96%66.65M | -35.05%21.58M | 135.31%15.97M | -85.14%8.94M | -33.34%20.16M | 130.92%78.37M | 123.74%33.22M | 23.45%-45.23M | --60.13M |
-Change in inventory | 316.00%10.92M | 439.50%262.27M | 76.76%130.75M | 878.13%83.67M | 2,215.43%52.91M | 83.90%-5.06M | 107.44%48.61M | 243.94%73.97M | 104.37%8.55M | ---2.5M |
-Change in payables and accrued expense | 1,007.51%63.67M | 72.24%-48.98M | 112.82%6.3M | -21.67%-40.39M | 46.77%-20.63M | 110.39%5.75M | -200.63%-176.43M | -5.68%-49.12M | -136.76%-33.19M | ---38.76M |
-Change in other current assets | 238.79%5.54M | -257.86%-14.46M | 42.79%16.52M | -2,016.36%-11.48M | -463.99%-15.52M | 45.14%-3.99M | 855.94%9.16M | -14.10%11.57M | 114.65%599K | --4.26M |
-Change in other current liabilities | 8.90%-19.27M | -27.74%14.99M | 80.31%26.67M | -111.23%-1.51M | -37.63%10.98M | 15.87%-21.15M | 73.88%20.74M | 111.81%14.79M | -76.56%13.48M | --17.61M |
-Change in other working capital | -51.15%-79.69M | -156.56%-55.87M | 14.90%-30.57M | -45.53%20.27M | 389.00%7.15M | -114.92%-52.72M | -104.54%-21.78M | -112.36%-35.92M | 28.98%37.21M | --1.46M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1,870.78%53.64M | 163.24%436.5M | 145.03%220.13M | 598.94%131.6M | -17.13%87.8M | 93.79%-3.03M | 731.94%165.82M | 23,017.60%89.84M | 188.84%18.83M | --105.95M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 7.38%-26.48M | -1.76%-94.95M | -68.05%-26.2M | 41.64%-17.57M | 13.23%-22.59M | -32.48%-28.59M | 8.13%-93.3M | 5.09%-15.59M | -44.18%-30.1M | -26.03M |
Net PPE purchase and sale | 7.43%-26.53M | 8.52%-95.18M | -8.46%-26.31M | 42.72%-17.36M | 13.43%-22.86M | -24.13%-28.66M | -2.40%-104.05M | -46.26%-24.26M | -45.36%-30.3M | ---26.41M |
Net other investing changes | -27.69%47K | -97.81%235K | -98.78%106K | -200.49%-207K | -27.35%271K | -95.68%65K | 20,968.63%10.75M | 5,453.21%8.66M | 835.71%206K | --373K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 7.38%-26.48M | -1.76%-94.95M | -68.05%-26.2M | 41.64%-17.57M | 13.23%-22.59M | -32.48%-28.59M | 8.13%-93.3M | 5.09%-15.59M | -44.18%-30.1M | ---26.03M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -1,015.55%-52.76M | -175.64%-255.59M | -72.48%-121.28M | -2,627.10%-108.68M | 45.75%-31.39M | -85.39%5.76M | -166.57%-92.73M | -510.08%-70.32M | -127.78%-3.99M | -57.86M |
Net issuance payments of debt | -525.12%-36.87M | -380.99%-188.96M | -52.51%-101.62M | -1,036.70%-90.09M | 84.14%-5.91M | -84.23%8.67M | -119.52%-39.29M | -425.36%-66.64M | -64.48%9.62M | ---37.27M |
Net common stock issuance | ---12.82M | -36.00%-55.69M | -455.93%-19.54M | -37.06%-18.58M | -41.60%-17.57M | --0 | 18.75%-40.95M | -1.01%-3.52M | -15.09%-13.55M | ---12.41M |
Proceeds from stock option exercised by employees | --0 | 2,525.00%210K | --0 | -12.50%7K | --21K | --182K | -98.33%8K | --0 | --8K | --0 |
Net other financing activities | 0.58%-3.07M | 10.78%-11.15M | 29.70%-116K | 77.19%-13K | 3.11%-7.93M | 24.44%-3.09M | -3.60%-12.5M | -511.11%-165K | 94.01%-57K | ---8.19M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -1,015.55%-52.76M | -175.64%-255.59M | -72.48%-121.28M | -2,627.10%-108.68M | 45.75%-31.39M | -85.39%5.76M | -166.57%-92.73M | -510.08%-70.32M | -127.78%-3.99M | ---57.86M |
Net cash flow | ||||||||||
Beginning cash position | 35.38%347.46M | -6.83%256.65M | 6.44%269.89M | -1.95%265.09M | -6.25%232.41M | -6.83%256.65M | 1.83%275.47M | -8.74%253.55M | -12.47%270.36M | --247.91M |
Current changes in cash | 0.97%-25.61M | 525.44%85.97M | 1,749.02%72.65M | 135.17%5.36M | 53.32%33.81M | 16.42%-25.86M | -275.80%-20.21M | 1,101.53%3.93M | 44.98%-15.25M | --22.06M |
Effect of exchange rate changes | -348.05%-4.01M | 247.88%4.84M | 693.97%4.92M | 63.52%-568K | -384.42%-1.13M | -52.20%1.62M | 121.28%1.39M | 69.15%-829K | 53.14%-1.56M | --398K |
End cash Position | 36.76%317.85M | 35.38%347.46M | 35.38%347.46M | 6.44%269.89M | -1.95%265.09M | -6.25%232.41M | -6.83%256.65M | -6.83%256.65M | -8.74%253.55M | --270.36M |
Free cash flow | 185.56%27.11M | 452.54%341.32M | 195.54%193.82M | 1,095.69%114.25M | -18.36%64.94M | 55.92%-31.69M | 148.32%61.77M | 486.32%65.58M | 72.71%-11.47M | --79.54M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |